Skip to main content

Advertisement

Log in

Parkinson’s disease showing progressive conduction aphasia

  • Case Report
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Patients with Parkinson’s disease (PD) may develop progressive dementia late in their clinical course. Dementia in PD is mostly related to neuropathological findings of extensive Lewy bodies (LBs), with or without the coexistence of Alzheimer’s disease (AD) pathology. Aphasia has been reported in patients with LB diseases with AD pathology; however, there have been no reports of typical PD patients developing progressive aphasia during their clinical course. We describe a female PD patient who later developed progressive conduction aphasia characterized by phonemic paraphasia and disturbance in repetition of short sentences without disturbance in writing or auditory comprehension. No episodes of fluctuations of attention, memory complaints, or planning errors were observed. She experienced episodes of visual hallucination. Her low scores on the Mini-Mental State Examination suggested impairment of orientation and attention, and her scores on Raven’s Coloured Progressive Matrices test indicated impaired visuospatial functions. However, her cognitive deficits were not sufficiently severe to impair her daily life. Brain magnetic resonance images revealed atrophy of the left superior temporal gyrus and widening of the left sylvian fissure. [18F]-fluorodeoxyglucose positron emission tomography revealed glucose hypometabolism in the left cerebral hemisphere. These findings may be related to conduction aphasia. During the progression of PD lesions, the brainstem LB is assumed to take an upward course, extend to the limbic system, and then extend to the neocortex. Conduction aphasia observed in our patient may be associated with an unusual progression of the LB pathology from the brainstem to the left temporoparietal lobe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707

    Article  PubMed  Google Scholar 

  2. Dubois B, Burn D, Goetz C et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324

    Article  PubMed  Google Scholar 

  3. Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(suppl):S81–S92

    PubMed  Google Scholar 

  4. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies, third report of the DLB consortium. Neurology 65:1863–1872

    Article  PubMed  CAS  Google Scholar 

  5. Henderson JM, Gai WP, Hely MA, Reid WGJ, Walker GL, Halliday GM (2001) Parkinson’s disease with late Pick’s dementia. Mov Disord 16:311–319

    Article  PubMed  CAS  Google Scholar 

  6. Caselli RJ, Beach TG, Sue LI, Connor DJ, Sabbagh MN (2002) Progressive aphasia with Lewy bodies. Dement Geriatr Cogn Disord 14:55–58

    Article  PubMed  Google Scholar 

  7. Monoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238–1248

    Google Scholar 

  8. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a cliniclo-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  PubMed  CAS  Google Scholar 

  9. Yoshita M, Hayashi M, Hirai S (1998) Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson’s disease. Nucl Med Commun 19:137–142

    Article  PubMed  CAS  Google Scholar 

  10. Axer H, von Keyserlingk AG, Berks G, von Keyserlingk DG (2001) Supra- and infrasylvian conduction aphasia. Brain Lang 76:317–331

    Article  PubMed  CAS  Google Scholar 

  11. Kimura N, Kumamoto T, Hanaoka T, Hazama Y, Nakamura K, Arakawa R (2008) Corticobasal degeneration presenting with progressive conduction aphasia. J Neurol Sci 269:163–168

    Article  PubMed  Google Scholar 

  12. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y (2009) Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry 80:366–370

    Article  PubMed  CAS  Google Scholar 

  13. Papapetropoulos S, McCorquodale DS, Gonzalez J, Jean-Gilles L, Mash DC (2006) Cortical and amygdalar Lewy body burden in Parkinson’s disease patients with visual hallucinations. Parkinsonism Relat Disord 12:253–256

    Article  PubMed  Google Scholar 

  14. Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800

    Article  PubMed  Google Scholar 

  15. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Sakai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakai, K., Ono, K., Harada, H. et al. Parkinson’s disease showing progressive conduction aphasia. Neurol Sci 33, 399–402 (2012). https://doi.org/10.1007/s10072-011-0751-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-011-0751-9

Keywords

Navigation